These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3706489)

  • 21. Immunopathogenesis of keratoconjunctivitis sicca in the dog.
    Williams DL
    Vet Clin North Am Small Anim Pract; 2008 Mar; 38(2):251-68, vi. PubMed ID: 18299006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Determination of tear film break-up time in keratoconjunctivitis sicca with a barrier filter].
    Pillunat LE; Christ T; Stodtmeister R
    Fortschr Ophthalmol; 1986; 83(1):105-7. PubMed ID: 3710336
    [No Abstract]   [Full Text] [Related]  

  • 23. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome.
    Marsh P; Pflugfelder SC
    Ophthalmology; 1999 Apr; 106(4):811-6. PubMed ID: 10201607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new rabbit model for keratoconjunctivitis sicca.
    Gilbard JP; Rossi SR; Gray KL
    Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):225-8. PubMed ID: 8591900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast sensitivity in patients with keratoconjunctivitis sicca before and after artificial tear application.
    Rieger G
    Graefes Arch Clin Exp Ophthalmol; 1993 Oct; 231(10):577-9. PubMed ID: 8224932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus (types 1 and 2) in the tear film in Sjogren's syndrome and HIV infection.
    Willoughby CE; Baker K; Kaye SB; Carey P; O'Donnell N; Field A; Longman L; Bucknall R; Hart CA
    J Med Virol; 2002 Nov; 68(3):378-83. PubMed ID: 12226825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The use of autologous serum in the treatment of the ocular surface diseases].
    Wilczyński M
    Klin Oczna; 2009; 111(10-12):363-8. PubMed ID: 20169898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mouse model of keratoconjunctivitis sicca.
    Dursun D; Wang M; Monroy D; Li DQ; Lokeshwar BL; Stern ME; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):632-8. PubMed ID: 11867577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of tear substitutes and their immediate effect on the precorneal tear film.
    Avisar R; Creter D; Levinsky H; Savir H
    Isr J Med Sci; 1997 Mar; 33(3):194-7. PubMed ID: 9313790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surface activity and wetting action of preparations of artificial tears].
    Chasovnikova LV; Formaziuk VE; Sergienko VI; Maĭchyk IuF
    Biull Eksp Biol Med; 1993 Apr; 115(4):368-70. PubMed ID: 8049395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-reported compliance with topical cyclosporine emulsion 0.05% and onset of the effects of increased tear production as assessed through patient surveys.
    Trattler W; Katsev D; Kerney D
    Clin Ther; 2006 Nov; 28(11):1848-56. PubMed ID: 17213005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new hypothesis on tear film stability.
    Liotet S; Van Bijsterveld OP; Kogbe O; Laroche L
    Ophthalmologica; 1987; 195(3):119-24. PubMed ID: 3696701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid assay of lactoferrin in keratoconjunctivitis sicca.
    McCollum CJ; Foulks GN; Bodner B; Shepard J; Daniels K; Gross V; Kelly L; Cavanagh HD
    Cornea; 1994 Nov; 13(6):505-8. PubMed ID: 7842709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Keratoconjunctivitis sicca in juvenile rheumatoid arthritis.
    Akinci A; Cakar N; Uncu N; Kara N; Acaroglu G
    Cornea; 2007 Sep; 26(8):941-4. PubMed ID: 17721292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical therapy for dry eyes.
    Gilbard JP
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 4)():484-8. PubMed ID: 3898481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of pH and osmolarity on the ability of tolerate artificial tears.
    Motolko M; Breslin CW
    Am J Ophthalmol; 1981 Jun; 91(6):781-4. PubMed ID: 7246701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.
    Pflugfelder SC; Maskin SL; Anderson B; Chodosh J; Holland EJ; De Paiva CS; Bartels SP; Micuda T; Proskin HM; Vogel R
    Am J Ophthalmol; 2004 Sep; 138(3):444-57. PubMed ID: 15364229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of nonisotonic solutions on tear film osmolality.
    Holly FJ; Lamberts DW
    Invest Ophthalmol Vis Sci; 1981 Feb; 20(2):236-45. PubMed ID: 7461925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tear film break up time (B.U.T.) in non-contact lens wearers and contact lens wearers in normal Indian population.
    Chopra SK; George S; Daniel R
    Indian J Ophthalmol; 1985; 33(4):213-6. PubMed ID: 3842827
    [No Abstract]   [Full Text] [Related]  

  • 40. [Actual information: Tenside in toothpaste].
    Peters S
    Quintessenz J; 1987 Nov; 17(11):1089-91. PubMed ID: 3484006
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.